Ticker
BMY

Price
58.37
Stock movement down
-0.32 (-0.55%)
Company name
Bristol-Myers Squibb Company
Exchange
(NYSE
,
Currency
USD
)
Sector
Healthcare >
Drug Manufacturers - General
Market cap
118.32B
Ent value
191.47B
Price/Sales
2.60
Price/Book
7.15
Div yield
4.11%
Div growth
7.34%
Growth years
12
FCF payout
38.05%
Trailing P/E
-
Forward P/E
8.42
PEG
-
EPS growth
5.14%
1 year return
16.79%
3 year return
2.86%
5 year return
0.50%
10 year return
-0.08%
Last updated: 2024-12-04

DIVIDENDS

Dividend yield - 5y

Loading...
Dividend yield data
Dividend per share2.40
Dividend yield4.11%
Payout frequencyQuarterly
Maximum yield6.05%
Average yield3.55%
Minimum yield2.66%
Discount to avg yield13.76%
Upside potential15.95%
Yield as % of max yield67.95%

Yield distribution (inverse percentile) - 5y

Loading...
Yield distribution data
Dividend yield4.11%
Current yield distribution21.19%
Yield at 100% (Min)2.66%
Yield at 90%2.85%
Yield at 80%2.93%
Yield at 50% (Median)3.20%
Yield at 20%4.39%
Yield at 10%4.81%
Yield at 0% (Max)6.05%

Dividend per share

Loading...
Dividend per share data
Years of growth12 years
CCC statusDividend Contender
Dividend per share2.40
Payout frequencyQuarterly
Ex-div date4 Oct 2024
EPS (TTM)-3.04
EPS (1y forward)6.93
EPS growth (5y)5.14%
EPS growth (5y forward)18.40%

Dividend growth

Loading...
Please create a free account or log in to access this chart
Dividend growth data
BMYS&P500
DGR MR5.26%-0.74%
DGR TTM5.26%7.63%
DGR 3 years-0.15%5.24%
DGR 5 years7.34%5.40%
DGR 10 years2.62%7.07%
DGR 15 years2.61%6.12%
Time since last change announced366 days
EPS growth (5y)5.14%
EPS growth (5y forward)18.40%

Payout ratio

Loading...
Please create a free account or log in to access this chart
Payout ratio data
EPS coverageFCF coverage
TTM-77.42%38.05%
Average--
Forward34.63%-

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF8.62
Price to FCF9.46
Price to EBITDA6.72
EV to EBITDA10.87

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales2.60
Price to Book7.15
EV to Sales4.21
Bristol-Myers Squibb Company (NYSE:BMY) Jefferies London Healthcare Conference November 19, 2024 4:30 AM ETCompany ParticipantsDavid Elkins -...
November 19, 2024

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

FINANCIALS

Per share

Loading...
Per share data
Current share count2.03B
EPS (TTM)-3.04
FCF per share (TTM)6.18

Income statement

Loading...
Income statement data
Revenue (TTM)45.53B
Gross profit (TTM)34.48B
Operating income (TTM)13.93B
Net income (TTM)-6.15B
EPS (TTM)-3.04
EPS (1y forward)6.93

Margins

Loading...
Margins data
Gross margin (TTM)75.71%
Operating margin (TTM)30.59%
Profit margin (TTM)-13.50%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash9.33B
Net receivables14.06B
Total current assets28.67B
Goodwill21.74B
Intangible assets33.17B
Property, plant and equipment13.13B
Total assets99.03B
Accounts payable3.54B
Short/Current long term debt57.41B
Total current liabilities25.82B
Total liabilities82.48B
Shareholder's equity16.55B
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)13.72B
Capital expenditures (TTM)1.22B
Free cash flow (TTM)12.51B
Dividends paid (TTM)4.76B

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-37.15%
Return on Assets-6.21%
Return on Invested Capital-8.49%
Cash Return on Invested Capital17.28%

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open58.57
Daily high58.79
Daily low57.59
Daily Volume9.36M
All-time high81.13
1y analyst estimate52.25
Beta0.43
EPS (TTM)-3.04
Dividend per share2.40
Ex-div date4 Oct 2024
Next earnings date6 Feb 2025

Downside potential

Loading...
Downside potential data
BMYS&P500
Current price drop from All-time high-28.05%-
Highest price drop-76.73%-56.47%
Date of highest drop16 Oct 20089 Mar 2009
Avg drop from high-34.10%-11.14%
Avg time to new high43 days12 days
Max time to new high4176 days1805 days

iO Charts is a Seeking Alpha partner

COMPANY DETAILS
BMY (Bristol-Myers Squibb Company) company logo
Marketcap
118.32B
Marketcap category
Large-cap
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, and neuroscience diseases. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation, and for the treatment of DVT/PE; Opdivo for various anti-cancer indications, including bladder, blood, CRC, head and neck, RCC, HCC, lung, melanoma, MPM, stomach and esophageal cancer; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of multiple myeloma; Abecma for the treatment of relapsed or refractory multiple myeloma; Reblozyl for the treatment of anemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi for the treatment of relapsed or refractory large B-cell lymphoma; Onureg for the treatment of AML; Inrebic for the treatment of myelofibrosis; Camzyos for the treatment of symptomatic obstructive HCM to enhance functional capacity and symptom; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; and Abraxane to treat breast cancer, NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in Princeton, New Jersey.
Employees
34100
SEC filings
CEO
Giovanni Caforio
Country
USA
City
New York
Stock type
Common stock
CCC status
Dividend Contender
Dividend Frequency
Quarterly
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...